Appendix 4D and Half-year Financial Report

Aug 25, 2026 at 6:25 PM EDT · Issued by Avecho Biotechnology Limited via ASX

Filed with ASX · Aug 25, 2026 at 6:25 PM EDT · 25 pages · English

On 6ix: 6ix.com/news/appendix-4d-and-half-year-financial-report-146

Release

Avecho Biotechnology Limited Appendix 4D Half-year report 1. Company details Name of entity: Avecho Biotechnology Limited ABN: 32 056 482 403 Reporting period: For the period ended 30 June 2026 Previous period: For the period ended 30 June 2025 2. Results...

Avecho Biotechnology Limited on 6ix

Earlier from Avecho Biotechnology

Avecho strengthens BD capability with senior appointmentAug 23
Small Holding Share Sale Facility CompletionAug 11
Japanese patent granted for CBD capsuleAug 2
June 2026 Quarterly Activities Report & Appendix 4CJul 28
Positive interim analysis advances Avecho Phase III insomnia programJun 29

Later from Avecho Biotechnology

Avecho enters final stage of Phase III insomnia trialAug 30
Avecho to present at the ASX SMIDcaps ConferenceSep 22
Avecho to present at the Canaccord Drug and Device ConfeOct 12
Response to ASX Price QueryOct 21
Change of Chief Financial OfficerOct 27

All Avecho Biotechnology news releases

Follow Avecho Biotechnology into a list and get an email when it puts out news.

Follow Avecho Biotechnology